Abstract
The natural resistance of a fraction of cells in a tumor to a conventional dose of chemotherapy can partly be overcome by high dose (HD) chemotherapy [1]. HD chemotherapy may kill more tumor cells but could also cause long lasting or irreversible bone marrow aplasia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lazarus HM, Herzig RH, Wolff SN et al. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation. Cancer Treat Rep 1985;69:473–7.
Gorin NC, Herzig G, Bull MI, Graw RG. Long-term preservation of bone marrow and stem cell pool in dogs. Blood 1978;51:257–65.
Thomas ED, Buckner CD, Clift RA. Marrow transplantation for acute non-lymphoblastic leukemia in first remission. N Engl J Med 1979;300:597–9.
Deisseroth A, Abrams RA. The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms. Cancer Treat Rep 1979;63:461–71.
De Vries EGE, Vriesendorp R, Meinesz AF, Mulder NH, Postmus PE, Sleijfer DTh. No narcosis for bone marrow harvest in autologous bone marrow transplantation. Blut 1984;49:419–21.
Arnaud F, Orie JML, Mulder NH et al. Bone marrow separation, purification and cryopreservation: application for autologous bone marrow transplantation (ABMT). Int J Art Org 1985;8:209–14.
Elias MK, Oenema B, Scholten JT, Das PC, Smit Sibinga CTh. Surge pump plateletapheresis: a method for effective depletion of white cells from machine collected single donor platelets. Plasma Ther Transf Ther 1985;6:381–96.
von Bartheld M, Arnaud F, Das PC, Smit Sibinga CTh. Cryopreservation of platelet concentrate: a comparison of DMSO and glycerol systems. In: Smit Sibinga CTh, Das PC, van Loghem JJ (eds). Blood transfusion and problems of bleeding. The Hague/Boston/London: Martinus Nijhoff Publishers 1982:89–95.
Philip T, Biron P, Maraninchi D et al. Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin’s lymphoma. Brit J Haemat 1985;60:599–609.
De Kraker J. Voute PA. The effect of high dose melphalan with autologous bone marrow transplantation in neuroblastoma patients with advanced disease. In: McVie JG, Dalesio O, Smith IE (eds). Autologous bone marrow transplantation and solid tumors. Raven Press 1984:153–6.
Postmus PE, Mulder NH, Sleijfer DTh, Meinesz AF, Vriesendorp R, de Vries EGE. High-dose etoposide for refractory malignancies: a phase I study. Cancer Treat Rep 1984;68:1471–4.
McElwain TJ, Hedley DW, Burton G et al. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high dose melphalan. Br J Cancer 1979;40:72–80.
Scheef W, Klein HO, Brock N et al. Controlled clinical studies with an antidote against the urotoxicity of oxazophophorines: Preliminary results. Cancer Treat Rep 1979;63:501–5.
Smith IE, Evans BD, Harland SJ, Millar JL. Autologous bone marrow rescue is unnecessary after very-high-dose cyclophosphamide. Lancet 1983;i:76–7.
Spitzer G, Verma DS, Fisher R et al. The myeloid progenitor cell — its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 1980;55:317–23.
Hartmann O, Beaujean F, Bayet S et al. Hematopoietic recovery following autologous bone marrow transplantation: Role of cryopreservation, number of cells infused and nature of high-dose chemotherapy. Eur J Cancer Clin Oncol 1985;21: 53–60.
Millar JL, Smith IE. The viability of marrow stored at 4°C. In: McVie JG, Dalesio O, Smith IE (eds). Autologous bone marrow transplantation and solid tumors. Raven Press 1984:9–12.
Patterson J, Prentice HG, Brenner MK et al. Graft rejection following HLA matched T-lymphocytes depleted bone marrow transplantation. Brit J Haemat 1986;63:221–30.
Shiobara S, Harada M, Mori T et al. Difference in posttransplant recovery of immune reactivity between allogeneic and autologous bone marrow transplantation. Transplant Proc 1982;15:429–33.
Gouyette A, Hartmann O, Pico GI. Pharmacokinetics of high-dose melphalan in children and adults. Cancer Chemother Pharmacol 1986;16:184–9.
Holthuis JJM, Postmus PE, van Oort WJ et al. Pharmacokinetics of high dose etoposide (VP 16–213). Proc Am Ass Clin Oncol 1986:5(abstract 113).
Postmus PE, Mulder NH, Elema JD. Graft versus host disease in autologous bone marrow transplantation. Cancer 1987 (in press).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Mulder, P.O.M. et al. (1987). Autologous Bone Marrow Transplantation in Solid Malignancies. In: Sibinga, C.T.S., Das, P.C., Engelfriet, C.P. (eds) White cells and platelets in blood transfusion. Developments in Hematology and Immunology, vol 19. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2089-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2089-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9238-8
Online ISBN: 978-1-4613-2089-0
eBook Packages: Springer Book Archive